Nebucort F Respules are inhalation suspension solutions for nebulization, each containing 2 ml with Formoterol fumarate dihydrate 20 mcg and Budesonide 0.5 mg. These Respules are indicated for the maintenance treatment of airways diseases characterized by reversible or chronic obstruction, including asthma and chronic obstructive pulmonary disease (COPD). The combination of Formoterol, a long-acting beta2-adrenergic agonist, and Budesonide, a corticosteroid, provides bronchodilation and anti-inflammatory effects, aiming to improve lung function, reduce symptoms, and minimize the risk of exacerbations. Nebucort F Respules should be used with a compatible nebulizer and are intended for twice-daily administration.